C3 and neoplasm: Several immune checkpoint genes (HAVCR2, CD47, LGALS9, and CD276) were gradually upregulated along the DC differentiation trajectory, especially at the late stage, revealing that C3-DC might suppress tumor immunity (Fig. 2e, f).